Pathological fractures in patients who have amyloidosis associated with dialysis. A report of five cases

Related Experiment Videos

J M Campistol1, M Solé, J Muñoz-Gómez

  • 1Department of Nephrology, University of Barcelona, Spain.

Insights

Patients on maintenance hemodialysis developed femoral neck fractures due to amyloid deposition. Beta-2-microglobulin was identified as the primary protein in these amyloid deposits, highlighting a complication of long-term dialysis.

Area of Science:

  • Nephrology
  • Orthopedic Surgery
  • Pathology

Background:

  • Maintenance hemodialysis is a life-sustaining treatment for end-stage renal disease.
  • Amyloidosis is a condition characterized by the abnormal deposition of proteins in various organs.
  • Beta-2-microglobulin amyloidosis is a known complication in patients undergoing long-term dialysis.

Observation:

  • Five patients undergoing maintenance hemodialysis presented with pathological fractures of the femoral neck.
  • These fractures were attributed to extensive amyloid deposition in the femoral neck.
  • Clinical presentation included severe bone pain and impaired mobility.

Findings:

  • Immunohistochemical analysis confirmed beta-2-microglobulin as the predominant protein in the amyloid deposits.
  • The amyloid accumulation led to weakening of the bone structure, resulting in fractures.
  • No other significant protein constituents were identified as major components.

Implications:

  • This finding underscores the risk of beta-2-microglobulin amyloidosis in dialysis patients, specifically affecting bone health.
  • Early recognition and potential interventions for amyloid deposition may be crucial for preventing skeletal complications.
  • Further research is warranted to explore preventative strategies and treatment options for dialysis-related amyloid arthropathy.

Related Concept Videos